Intellio Healthcare is a healthcare solutions firm focused on providing global support that facilitates healthcare organizations in providing the best quality health at the most affordable cost. At Intellio, we bring together a global team that harbors a passion for health access and innovation. The experience and outreach of our teams is the core success driver of our underlying philosophy of providing the best services at the most affordable costs. We have identified and developed the relationships with our partners that we leverage for our clients to serve their needs in a timely and consistent manner. We offer a complete range of healthcare solutions for health sector - clinics, diagnostic centres and hospitals.

• Member of core team responsible for international business development for the Apollo Group, achieving revenues of US $ 85 million in 2016-17 from international markets• Led the expansion of Apollo’s presence in 10 African countries including Francophone Africa; developed strategic partnerships with multiple stakeholders, including MOUs with Governments (First ever by any Indian Hospital)• Executed capacity building initiatives for the African healthcare sector by building public private partnerships, up skilling, knowledge transfer and sharing experience from India’s Healthcare growth story• Received special appreciation from High Commissioners/Ambassadors of partner nations to India for strengthening healthcare partnerships

Advise Fortune 100 pharmaceutical firms on R&D strategy, portfolio management, and perform commercial assessment of high priority disease areas, for identifying and evaluating unmet need, revenue potential, competitive and emerging landscape, strategic fit for disease indications, and communicate findings & recommendations to the clients to support corporate strategy, and business development decision making.Conducted a comprehensive competitive disease landscape assessment using secondary and qualitative primary research, and LCM prioritization of a new oncology entrant for a Fortune 100 biotechnology company.